JPWO2023156409A5 - - Google Patents
Info
- Publication number
- JPWO2023156409A5 JPWO2023156409A5 JP2024569671A JP2024569671A JPWO2023156409A5 JP WO2023156409 A5 JPWO2023156409 A5 JP WO2023156409A5 JP 2024569671 A JP2024569671 A JP 2024569671A JP 2024569671 A JP2024569671 A JP 2024569671A JP WO2023156409 A5 JPWO2023156409 A5 JP WO2023156409A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cdr
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263268040P | 2022-02-15 | 2022-02-15 | |
| US63/268,040 | 2022-02-15 | ||
| US202263269000P | 2022-03-08 | 2022-03-08 | |
| US63/269,000 | 2022-03-08 | ||
| PCT/EP2023/053681 WO2023156409A1 (en) | 2022-02-15 | 2023-02-14 | Methods of treating blood disorders with vwf-targeted monospecific antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025507448A JP2025507448A (ja) | 2025-03-18 |
| JP2025507448A5 JP2025507448A5 (https=) | 2026-02-20 |
| JPWO2023156409A5 true JPWO2023156409A5 (https=) | 2026-02-20 |
Family
ID=85278579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024569671A Pending JP2025507448A (ja) | 2022-02-15 | 2023-02-14 | Ｖｗｆ標的化単特異性抗体により血液障害を処置する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250154283A1 (https=) |
| EP (1) | EP4479435A1 (https=) |
| JP (1) | JP2025507448A (https=) |
| KR (1) | KR20240159860A (https=) |
| CN (1) | CN119032109A (https=) |
| AU (1) | AU2023221511A1 (https=) |
| CA (1) | CA3244108A1 (https=) |
| WO (1) | WO2023156409A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR133583A1 (es) * | 2023-08-16 | 2025-10-15 | Hemab Aps | Métodos para tratar trastornos de la sangre con anticuerpos monoespecíficos dirigidos a vwf |
| WO2025174998A1 (en) * | 2024-02-13 | 2025-08-21 | Invetx, Inc. | Anti-il-31ra antibodies and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201707139D0 (en) * | 2017-05-04 | 2017-06-21 | Imp Innovations Ltd | Polypeptides |
-
2023
- 2023-02-14 CN CN202380034172.8A patent/CN119032109A/zh active Pending
- 2023-02-14 JP JP2024569671A patent/JP2025507448A/ja active Pending
- 2023-02-14 WO PCT/EP2023/053681 patent/WO2023156409A1/en not_active Ceased
- 2023-02-14 US US18/838,515 patent/US20250154283A1/en active Pending
- 2023-02-14 CA CA3244108A patent/CA3244108A1/en active Pending
- 2023-02-14 AU AU2023221511A patent/AU2023221511A1/en active Pending
- 2023-02-14 KR KR1020247030582A patent/KR20240159860A/ko active Pending
- 2023-02-14 EP EP23705521.5A patent/EP4479435A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024009818A5 (https=) | ||
| JP6742245B2 (ja) | 多重特異性抗体 | |
| US20220162314A1 (en) | Fusions with cd8 antigen binding molecules for modulating immune cell function | |
| GB2595299A (en) | Modified immunoglobulin FC regions | |
| US20220119549A1 (en) | Shielded biologics with masking domains to shield antigen binding capability of biologics and uses thereof | |
| RU2019108429A (ru) | Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения | |
| JP7128819B2 (ja) | Ａｄａｍ９結合分子、およびその使用方法 | |
| JP2021511298A5 (https=) | ||
| JP2026510833A (ja) | 抗ｃｄ２８組成物 | |
| JPWO2023156409A5 (https=) | ||
| JPWO2021240388A5 (https=) | ||
| TW202525853A (zh) | 抗ｃｄ２０ｘ抗ｃｄ２８組合療法 | |
| JPWO2020128870A5 (https=) | ||
| JP2025514763A (ja) | Ｆｃガンマ受容体への結合が低減されたキメラ重鎖定常ドメイン及びその使用 | |
| JPWO2022047243A5 (https=) | ||
| US20260055171A1 (en) | Vegf antagonists and methods of use thereof | |
| JPWO2019140273A5 (https=) | ||
| WO2021150266A1 (en) | Agents that interfere with il-1beta receptor signalling | |
| JP7192042B2 (ja) | Ｌａｇ‐３結合分子及びその使用方法 | |
| US20250011449A1 (en) | Circularized antibody molecules | |
| US20250361309A1 (en) | Tumor-targeted split il12 receptor agonists | |
| JPWO2023023465A5 (https=) | ||
| KR20250113537A (ko) | 항-cd3 항체 | |
| WO2024107731A2 (en) | Anti-pd-l1 antibodies | |
| JP2024546961A (ja) | Ｈｉｖ感染に対する組合せ療法およびその使用 |